CNS Lymphoma Subtypes
Featured Research
See all papers →
Treatment Pipeline
Active Trials Spotlight
See all trials →
Molecular Markers
Trending This Week

Clinical Actionability

Evidence Level

What is a Clinical Trial?

Clinical research is any scientific investigation with human beings. When it involves evaluating new treatments with medications or medical devices, we call them clinical trials. Every medication you buy at the pharmacy — and the information on its label — is the result of clinical trials. They are the only way a promising laboratory discovery becomes an approved treatment available to patients.

Through clinical trials, doctors determine whether new treatments are safe and if they work better than current treatments. This rigorous process ensures that only therapies proven to be both safe and effective reach patients in clinical practice.

Understanding
How Clinical Trials Work
Clinical trials are conducted by diverse organizations working together to advance medical knowledge. Understanding who runs these studies and how they operate helps you make informed decisions about participation.

Government Agencies

The National Cancer Institute and other federal agencies fund trials to advance public health. These studies often focus on understanding disease mechanisms and testing promising new approaches.

Universities

Academic medical centers conduct investigator-initiated trials, often exploring innovative combinations or novel approaches developed in their research laboratories.

Pharmaceutical Companies

Drug manufacturers sponsor trials to test new medications and seek regulatory approval. These studies follow strict protocols and safety standards set by international health authorities.

Did you know?
Clinical trials only happen because people like you voluntarily choose to participate. The effective treatments of tomorrow depend on what we learn from clinical trials today — every participant plays a vital role in advancing medicine.
10–15
Years to develop
6
Stages to approval
3,000+
Phase 3 participants
100%
Voluntary participation
The Journey
From Laboratory to Patient
Before a new treatment reaches patients, it must pass through a rigorous series of stages. If a treatment proves unsafe or ineffective at any stage, the research is stopped immediately to protect participants.
Pre-Clinical
Lab Research
Scientists test in cell cultures and animal models to understand how the treatment works and identify the right dose.
1
Phase 1
Safety & Dosage
A small group receives the treatment for the first time. The goal is to evaluate safety and determine the right dosage range.
20–80
2
Phase 2
Effectiveness
A larger group receives the treatment to evaluate whether it is effective against the target condition and assess safety further.
100–300
3
Phase 3
Comparison
Large groups compare the new treatment to the current standard of care. This generates the evidence needed for regulatory approval.
1,000–3,000+
Approval
Regulatory Review
Agencies like FDA, EMA, or ANVISA review all trial data and decide whether to approve the treatment for general use.
4
Phase 4
Monitoring
Tracks long-term safety and real-world outcomes after approval, including rare side effects across diverse populations.

Your Safety Comes First

Every clinical trial must be reviewed and approved by an independent ethics committee before it can begin. This committee ensures the study is designed to protect participants, that potential benefits justify any risks, and that you receive complete information before deciding to participate.

Participant Rights
What Are My Rights?

Informed Consent

You will receive a detailed explanation of the study, its risks, and potential benefits before you agree to participate.

Withdraw Anytime

You can leave the trial at any time, for any reason, without it affecting your standard medical care.

Privacy Protected

Your personal and medical data are kept strictly confidential and are protected by law throughout and after the study.

Benefits
Why Consider a Clinical Trial?

Early Access

Access promising new therapies before they are widely available to the public.

Expert Monitoring

Close follow-up by a specialized research team throughout the entire study duration.

Advance Research

Help researchers develop better treatments that may benefit future patients with the same condition.

No Extra Cost

Study-related treatments and procedures are typically provided at no cost to participants. Some trials also cover travel and other expenses.

Getting Started
How to Find and Evaluate Clinical Trials
Finding the right clinical trial involves careful research and collaboration with your medical team. Follow these steps to identify trials that match your situation and goals.
1

Gather Your Medical Details

Create a checklist with your specific diagnosis, treatment history, current medications, and any biomarker or genetic test results. This information helps determine which trials may be suitable for your situation.

2

Search Multiple Sources

Use Zyntha's personalized matching, ClinicalTrials.gov, and other databases to find relevant studies. Different sources may list different trials, so searching broadly increases your options.

3

Review Protocol Summaries

Each trial has a protocol summary describing who can participate, the study's goals, treatment details, and location. Pay close attention to eligibility criteria and what participation involves.

4

Discuss with Your Doctor

Share promising trials with your oncologist. They can help evaluate whether a trial fits your treatment plan and may assist in contacting the research team to discuss eligibility.

5

Ask Key Questions

Contact the trial team to learn about time commitments, potential side effects, what happens if the treatment doesn't work, and how your care will be managed during and after the study.

6

Make Your Decision

If a trial seems right for you, schedule an appointment with the research team to learn more. Remember, you can change your mind at any time, even after enrollment.

Additional Resources

NCI Trial Guide Six-step online guide from the National Cancer Institute
NCI Cancer Information Service 1-800-4-CANCER — Free help finding trials

Common Concerns

Will I receive a placebo?
In cancer trials, placebos are rare. Most trials compare a new treatment plus standard care versus standard care alone. You will always receive at least the standard of care.
Can I leave the trial at any time?
Yes. Participation is always voluntary. You can withdraw at any time without affecting your standard medical care.
How do I know if I'm eligible?
Each trial has specific criteria (diagnosis, treatment history, age, etc.). Use our search tool to find trials relevant to your specific diagnosis.
What happens if the treatment doesn't work?
If the treatment proves unsafe or ineffective at any stage, the research is stopped immediately. You will continue to receive the standard of care and your medical team will discuss alternative options with you.
Who oversees the safety of the trial?
An independent ethics committee (IRB/EC) reviews every trial before it begins and monitors it throughout. Regulatory agencies like the FDA, EMA, and ANVISA also provide oversight to ensure participant safety.